Emcure Pharmaceuticals Limited (NSE:EMCURE)

Market Cap	188.63B
Revenue (ttm)	75.51B
Net Income (ttm)	6.08B
Shares Out	189.43M
EPS (ttm)	32.85
PE Ratio	30.31
Forward PE	22.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89,475
Average Volume	127,642
Open	992.00
Previous Close	992.00
Day's Range	980.00 - 1,009.30
52-Week Range	941.50 - 1,580.00
Beta	n/a
RSI	26.83
Earnings Date	Feb 6, 2025

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral mol...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 10,852
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EMCURE

Financial Performance

In 2023, Emcure Pharmaceuticals's revenue was 66.58 billion, an increase of 11.23% compared to the previous year's 59.86 billion. Earnings were 4.98 billion, a decrease of -6.36%.